The DOI matches its Crossref record; 122 of the 122 references it cites were found in a registry or an index.
Poxvirus tropism
Open accessAbstract
Despite the success of the WHO-led smallpox eradication programme a quarter of a century ago, there remains considerable fear that variola virus, or other related pathogenic poxviruses such as monkeypox, could re-emerge and spread disease in the human population. Even today, we are still mostly ignorant about why most poxvirus infections of vertebrate hosts show strict species specificity, or how zoonotic poxvirus infections occur when poxviruses occasionally leap into novel host species. Poxvirus tropism at the cellular level seems to be regulated by intracellular events downstream of virus binding and entry, rather than at the level of specific host receptors as is the case for many other viruses. This review summarizes our current understanding of poxvirus tropism and host range, and discusses the prospects of exploiting host-restricted poxvirus vectors for vaccines, gene therapy or tissue-targeted oncolytic viral therapies for the treatment of human cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743
The challenge of emerging and re-emerging infectious diseases
Morens, D. M., Folkers, G. K., & Fauci, A. S. (2004) · Nature · doi:10.1038/nature02759 · Cited by 2,103
Viruses and interferon: a fight for supremacy
Katze, M. G., He, Y., & Gale, M. (2002) · Nature Reviews Immunology · doi:10.1038/nri888 · Cited by 1,419
The Detection of Monkeypox in Humans in the Western Hemisphere
Reed, K. D., Melski, J. W., Graham, M. B., Regnery, R. L., Sotir, M. J., Wegner, M. V., Kazmierczak, J. J., Stratman, E. J., Li, Y., Fairley, J. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032299 · Cited by 1,098
The Mouse in Biomedical Research
(1983) · Elsevier eBooks · doi:10.1016/c2013-0-10677-0 · Cited by 1,012
Sen, G. C. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.255 · Cited by 968
The ankyrin repeat as molecular architecture for protein recognition
Mosavi, L. K., Cammett, T. J., Desrosiers, D. C., & Peng, Z. (2004) · Protein Science · doi:10.1110/ps.03554604 · Cited by 907
Human monkeypox: an emerging zoonosis
Di Giulio, D. B., & Eckburg, P. B. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00856-9 · Cited by 798
How Viruses Enter Animal Cells
Smith, A. E., & Helenius, A. (2004) · Science · doi:10.1126/science.1094823 · Cited by 734
Virus entry: molecular mechanisms and biomedical applications
Dimitrov, D. S. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro817 · Cited by 701
Seet, B. T., Johnston, J. B., Brunetti, C. R., Barrett, J. W., Everett, H., Cameron, C., Sypula, J., Nazarian, S. H., Lucas, A., & McFadden, G. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141049 · Cited by 666
Self-citationJackson, R. J., Ramsay, A. J., Christensen, C. D., Beaton, S., Hall, D. F., & Ramshaw, I. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.3.1205-1210.2001 · Cited by 565
The formation and function of extracellular enveloped vaccinia virus
Smith, G. L., Vanderplasschen, A., & Law, M. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-12-2915 · Cited by 559
Antoine, G., Scheiflinger, F., Dorner, F., & Falkner, F. G. (1998) · Virology · doi:10.1006/viro.1998.9123 · Cited by 507
Meyer, H., Sutter, G., & Mayr, A. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-5-1031 · Cited by 474
A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling
Bowie, A., Kiss-Toth, E., Symons, J. A., Smith, G. L., Dower, S. K., & O'Neill, L. A. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160027697 · Cited by 466
Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox
Earl, P. L., Americo, J. L., Wyatt, L. S., Eller, L. A., Whitbeck, J. C., Cohen, G. H., Eisenberg, R. J., Hartmann, C. J., Jackson, D. L., Kulesh, D. A., et al. (2004) · Nature · doi:10.1038/nature02331 · Cited by 455
Intrinsic immunity: a front-line defense against viral attack
Bieniasz, P. D. (2004) · Nature Immunology · doi:10.1038/ni1125 · Cited by 454
Buller, R. M. L., & Palumbo, G. J. (1991) · Microbiological Reviews · doi:10.1128/mmbr.55.1.80-122.1991 · Cited by 452
Yu, Y. A., Shabahang, S., Timiryasova, T. M., Zhang, Q., Beltz, R., Gentschev, I., Goebel, W., & Szalay, A. A. (2004) · Nature Biotechnology · doi:10.1038/nbt937 · Cited by 423
Poxvirus genomes: a phylogenetic analysis
Gubser, C., Hué, S., Kellam, P., & Smith, G. L. (2004) · Journal of General Virology · doi:10.1099/vir.0.19565-0 · Cited by 406
Actin-based motility of vaccinia virus mimics receptor tyrosine kinase signalling
Frischknecht, F., Moreau, V., Röttger, S., Gonfloni, S., Reckmann, I., Superti-Furga, G., & Way, M. (1999) · Nature · doi:10.1038/44860 · Cited by 404
The Poxvirus Protein A52R Targets Toll-like Receptor Signaling Complexes to Suppress Host Defense
Harte, M. T., Haga, I. R., Maloney, G., Gray, P., Reading, P. C., Bartlett, N. W., Smith, G. L., Bowie, A., & O'Neill, L. A. J. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021652 · Cited by 370
McCart, J. A., Ward, J. M., Lee, J., Hu, Y., Alexander, H. R., Libutti, S. K., Moss, B., & Bartlett, D. L. (2001) · PubMed · Cited by 366
Vaccinia Virus Inhibits the Maturation of Human Dendritic Cells: A Novel Mechanism of Immune Evasion
Engelmayer, J., Larsson, M., Subklewe, M., Chahroudi, A., Cox, W. I., Steinman, R. M., & Bhardwaj, N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6762 · Cited by 365
A27L Protein Mediates Vaccinia Virus Interaction with Cell Surface Heparan Sulfate
Chung, C.-S., Hsiao, J.-C., Chang, Y.-S., & Chang, W. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1577-1585.1998 · Cited by 355
Blanchard, T. J., Andrea, P., Alcami, A., & Smith, G. L. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-5-1159 · Cited by 336
Carroll, M. W., & Moss, B. (1997) · Virology · doi:10.1006/viro.1997.8845 · Cited by 331
Genome Sequence of a Human Tumorigenic Poxvirus: Prediction of Specific Host Response-Evasion Genes
Senkevich, T. G., Bugert, J. J., Sisler, J. R., Koonin, E. V., Darai, G., & Moss, B. (1996) · Science · doi:10.1126/science.273.5276.813 · Cited by 327
Lin, C.-L., Chung, C.-S., Heine, H. G., & Chang, W. (2000) · Journal of Virology · doi:10.1128/jvi.74.7.3353-3365.2000 · Cited by 322
Antonio Chiocca, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc948 · Cited by 306
Monkeypox Transmission and Pathogenesis in Prairie Dogs
Guarner, J., Johnson, B. J., Paddock, C. D., Shieh, W.-J., Goldsmith, C. S., Reynolds, M. G., Damon, I. K., Regnery, R. L., Zaki, S. R., & the Veterinary Monkeypox Virus Working Group (2004) · Emerging Infectious Diseases · doi:10.3201/eid1003.030878 · Cited by 290
Meyer, H. E., Perrichot, M., Stemmler, M., Emmerich, P., SCHMITZ, H. E., Varaine, F., Shungu, R., Tshioko, F., & Formenty, P. B. H. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.8.2919-2921.2002 · Cited by 287
Hsiao, J.-C., Chung, C.-S., & Chang, W. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8750-8761.1999 · Cited by 282
Belyakov, I. M., Earl, P., Dzutsev, A., Kuznetsov, V. A., Lemon, M., Wyatt, L. S., Snyder, J. T., Ahlers, J. D., Franchini, G., Moss, B., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1233578100 · Cited by 278
Innate Sensing of Viruses by Toll-Like Receptors
Boehme, K. W., & Compton, T. (2004) · Journal of Virology · doi:10.1128/jvi.78.15.7867-7873.2004 · Cited by 265
Broyles, S. S. (2003) · Journal of General Virology · doi:10.1099/vir.0.18942-0 · Cited by 252
Wyatt, L. S., Earl, P. L., Eller, L. A., & Moss, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401165101 · Cited by 247
DiPerna, G., Stack, J., Bowie, A. G., Boyd, A., Kotwal, G., Zhang, Z., Arvikar, S., Latz, E., Fitzgerald, K. A., & Marshall, W. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400567200 · Cited by 233
Smith, E. J., Marié, I., Prakash, A., Garcı́a-Sastre, A., & Levy, D. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008717200 · Cited by 224
Locker, J. K., Kuehn, A., Schleich, S., Rutter, G., Hohenberg, H., Wepf, R., & Griffiths, G. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.7.2497 · Cited by 194
Sutter, G., & Staib, C. (2003) · Current Drug Target -Infectious Disorders · doi:10.2174/1568005033481123 · Cited by 190
The Role of the PKR-Inhibitory Genes, E3L and K3L, in Determining Vaccinia Virus Host Range
Langland, J. O., & Jacobs, B. L. (2002) · Virology · doi:10.1006/viro.2002.1479 · Cited by 186
Greber, U. F. (2002) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s00018-002-8453-3 · Cited by 186
Vaccinia virus host range genes
Perkus, M. E., Goebel, S. J., Davis, S. W., Johnson, G. P., Limbach, K., Norton, E. K., & Paoletti, E. (1990) · Virology · doi:10.1016/0042-6822(90)90296-4 · Cited by 180
Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier
Wang, F., Ma, Y., Barrett, J. W., Gao, X., Loh, J., Barton, E., Virgin, H. W., & McFadden, G. (2004) · Nature Immunology · doi:10.1038/ni1132 · Cited by 180
Self-citationThe Vaccinia Virus K1L Gene Product Inhibits Host NF-κB Activation by Preventing IκBα Degradation
Shisler, J. L., & Jin, X.-L. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3553-3560.2004 · Cited by 177
Extensive gene gain associated with adaptive evolution of poxviruses
McLysaght, A., Baldi, P. F., & Gaut, B. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2136653100 · Cited by 176
Intracellular and extracellular vaccinia virions enter cells by different mechanisms.
Vanderplasschen, A., Hollinshead, M., & Smith, G. L. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-4-877 · Cited by 173
Jahrling, P. B., Hensley, L. E., Martinez, M. J., LeDuc, J. W., Rubins, K. H., Relman, D. A., & Huggins, J. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405954101 · Cited by 171
The exit of Vaccinia virus from infected cells
Smith, G. L., & Law, M. (2004) · Virus Research · doi:10.1016/j.virusres.2004.08.015 · Cited by 165
Src Mediates a Switch from Microtubule- to Actin-Based Motility of Vaccinia Virus
Newsome, T. P., Scaplehorn, N., & Way, M. (2004) · Science · doi:10.1126/science.1101509 · Cited by 161
Vaccinia virus encodes a previously uncharacterized mitochondrial-associated inhibitor of apoptosis
Wasilenko, S. T., Stewart, T. L., Meyers, A. F. A., & Barry, M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235583100 · Cited by 154
Blasco, R., Sisler, J. R., & Moss, B. A. (1993) · Journal of Virology · doi:10.1128/jvi.67.6.3319-3325.1993 · Cited by 153
Use of Chemokine Receptors by Poxviruses
Lalani, A. S., Masters, J., Zeng, W., Barrett, J. W., Pannu, R., Everett, H., Arendt, C., & McFadden, G. (1999) · Science · doi:10.1126/science.286.5446.1968 · Cited by 151
Self-citationZoonotic poxvirus infections in humans
Lewis‐Jones, S. (2004) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200404000-00003 · Cited by 140
Bronte, V., Carroll, M. W., Goletz, T. J., Wang, M. L., Overwijk, W. W., Marincola, F. M., Rosenberg, S. A., Moss, B., & Restifo, N. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3183 · Cited by 139
Andrade, A. A., Silva, P. N. G., Pereira, A. C. T. D. C., Sousa, L. P., Ferreira, P. C. P., Gazzinelli, R. T., Kroon, E. G., Ropert, C., & Bonjardim, C. A. (2004) · Biochemical Journal · doi:10.1042/bj20031375 · Cited by 139
Epidermal growth factor receptor occupancy inhibits vaccinia virus infection
Eppstein, D. A., Marsh, Y. V., Schreiber, A. B., Newman, S. R., Todaro, G. J., & NESTOR, J. J. J. (1985) · Nature · doi:10.1038/318663a0 · Cited by 134
Delano, M. L., & Brownstein, D. G. (1995) · Journal of Virology · doi:10.1128/jvi.69.9.5875-5877.1995 · Cited by 133
Lin, E. E., & Nemunaitis, J. J. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700733 · Cited by 130
Smallpox: anything to declare?
Smith, G. L., & McFadden, G. (2002) · Nature reviews. Immunology · doi:10.1038/nri845 · Cited by 123
Self-citationCellular Gene Expression Survey of Vaccinia Virus Infection of Human HeLa Cells
Guerra, S., López-Fernández, L. A., Pascual-Montano, A., Muñoz, M., Harshman, K., & Estéban, M. (2003) · Journal of Virology · doi:10.1128/jvi.77.11.6493-6506.2003 · Cited by 122
Rubins, K., Hensley, L. E., Jahrling, P. B., Whitney, A. R., Geisbert, T. W., Huggins, J. W., Owen, A. B., LeDuc, J. W., Brown, P. O., & Relman, D. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405759101 · Cited by 121
Smith, G. L., Murphy, B. J., & Law, M. (2003) · Annual Review of Microbiology · doi:10.1146/annurev.micro.57.030502.091037 · Cited by 117
Hsiao, J., Chung, C.-S., & Chang, W. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8374-8379.1998 · Cited by 115
A cowpox virus gene required for multiplication in Chinese hamster ovary cells
Spehner, D., Gillard, S., Drillien, R., & Kirn, A. (1988) · Journal of Virology · doi:10.1128/jvi.62.4.1297-1304.1988 · Cited by 114
Jenne, L., Hauser, C. J., Arrighi, J.-F., Saurat, J. ‐., & Hügin, A. W. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301287 · Cited by 113
Beattie, E., Paoletti, E., & Tartaglia, J. (1995) · Virology · doi:10.1006/viro.1995.1342 · Cited by 112
Vaccinia Virus Entry into Cells Is Dependent on a Virion Surface Protein Encoded by the A28L Gene
Senkevich, T. G., Ward, B. M., & Moss, B. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.5.2357-2366.2004 · Cited by 108
Ignatius, R., Marovich, M., Mehlhop, E., Villamide, L., Mahnke, K., Cox, W. I., Isdell, F., Frankel, S. S., Mascola, J. R., Steinman, R. M., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.23.11329-11338.2000 · Cited by 107
Kettle, S., BLAKE, N. W., Law, K. M., et al. (1995) · Virology · doi:10.1016/s0042-6822(95)80028-x · Cited by 104
Everett, H., Barry, M., Sun, X., Lee, S. F., Frantz, C., Berthiaume, L. G., McFadden, G., & Bleackley, R. C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011247 · Cited by 103
Self-citationImmune Response to Poxvirus Infections in Various Animals
Smith, S. A., & Kotwa, G. J. (2002) · Critical Reviews in Microbiology · doi:10.1080/1040-840291046722 · Cited by 103
Host-range restriction of vaccinia virus E3L-specific deletion mutants
Beattie, E., Kauffman, E. B., Martínez, H. B., Perkus, M. E., Jacobs, B. L., Paoletti, E., & Tartaglia, J. (1996) · Virus Genes · doi:10.1007/bf00370005 · Cited by 102
Macen, J., Garner, R., Musy, P.-Y., Brooks, M., Turner, P., Moyer, R. W., McFadden, G., & Bleackley, R. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9108 · Cited by 99
Self-citationChaudhri, G., Panchanathan, V., Buller, R. M. L., van den Eertwegh, A. J. M., Claassen, E., Zhou, J., de Chazal, R., Laman, J. D., & Karupiah, G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402949101 · Cited by 99
A Mitogenic Signal Triggered at an Early Stage of Vaccinia Virus Infection
de Magalhães, J. C., Andrade, A. A., Silva, P. N. G., Sousa, L. P., Ropert, C., Ferreira, P. C. P., Kroon, E. G., Gazzinelli, R. T., & Bonjardim, C. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100183200 · Cited by 98
Franchini, G., Gurunathan, S., Baglyos, L., Plotkin, S. A., & Tartaglia, J. (2004) · Expert Review of Vaccines · doi:10.1586/14760584.3.4.s75 · Cited by 97
Drillien, R., Spehner, D., Bohbot, A., & Hanau, D. (2000) · Virology · doi:10.1006/viro.2000.0203 · Cited by 96
Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers
Zeh, H. J., & Bartlett, D. L. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700549 · Cited by 95
Modified Vaccinia Ankara: Potential as an Alternative Smallpox Vaccine
McCurdy, L., Larkin, B. D., Martin, J. E., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/421266 · Cited by 95
Molecular Chaperone Hsp90 Is Important for Vaccinia Virus Growth in Cells
Hung, J., Chung, C.-S., & Chang, W. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.1379-1390.2002 · Cited by 95
Host range deletion mutant of vaccinia virus defective in human cells
Drillien, R., Koehren, F., & Kirn, A. (1981) · Virology · doi:10.1016/0042-6822(81)90351-2 · Cited by 90
Myxoma Virus M11L Prevents Apoptosis through Constitutive Interaction with Bak
Wang, G., Barrett, J. W., Nazarian, S. H., Everett, H., Gao, X., Bleackley, C., Colwill, K., Moran, M. F., & McFadden, G. (2004) · Journal of Virology · doi:10.1128/jvi.78.13.7097-7111.2004 · Cited by 90
Self-citationGuerra, S., López-Fernández, L. A., Conde-Álvarez, R., Pascual-Montano, A., Harshman, K., & Estéban, M. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.5820-5834.2004 · Cited by 84
Katsafanas, G. C., & Moss, B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411033200 · Cited by 83
Oie, K. L., & Pickup, D. J. (2001) · Virology · doi:10.1006/viro.2001.1090 · Cited by 82
Camus-Bouclainville, C., Fiette, L., Bouchiha, S., Pignolet, B., Counor, D., Filipe, C., Gelfi, J., & Messud-Petit, F. (2004) · Journal of Virology · doi:10.1128/jvi.78.5.2510-2516.2004 · Cited by 82
Engelmayer, J., Larsson, M., Lee, A. W.-T., Lee, M., Cox, W. I., Steinman, R. M., & Bhardwaj, N. (2001) · Journal of Virology · doi:10.1128/jvi.75.5.2142-2153.2001 · Cited by 79
Pastoret, P.-P., & Vanderplasschen, A. (2003) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/s0147-9571(03)00019-5 · Cited by 79
A Poxvirus Protein with a RING Zinc Finger Motif Is of Crucial Importance for Virulence
Senkevich, T. G., Koonin, E. V., & Buller, R. M. L. (1994) · Virology · doi:10.1006/viro.1994.1014 · Cited by 76
McCart, J. A., Mehta, N., Scollard, D. A., Reilly, R. M., Carrasquillo, J. A., Tang, N., Deng, H., Miller, M. S., Xu, H. M., Libutti, S. K., et al. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.06.158 · Cited by 76
The Poxvirus p28 Virulence Factor Is an E3 Ubiquitin Ligase
Huang, J., Huang, Q. Q., Zhou, X., Shen, M., Yen, A., Yu, S., Dong, G., Qu, K., Huang, P., Anderson, E. M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410583200 · Cited by 75
Vaccinia as a vector for gene delivery
Guo, Z. S., & Bartlett, D. L. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.6.901 · Cited by 69
Vaccinia virus induces apoptosis of infected macrophages
Humlová, Z., Vokurka, M., Estéban, M., & Mělková, Z. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-11-2821 · Cited by 65
Karupiah, G., Chen, J.-H., Nathan, C., Mahalingam, S., & MacMicking, J. D. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7703-7706.1998 · Cited by 64
Type 1 and type 2 cytokines in antiviral defense
Karupiah, G. (1998) · Veterinary Immunology and Immunopathology · doi:10.1016/s0165-2427(98)00086-5 · Cited by 62
Inhibition of Interferons by Ectromelia Virus
Smith, V. P., & Alcamí, A. (2002) · Journal of Virology · doi:10.1128/jvi.76.3.1124-1134.2002 · Cited by 61
Nerenberg, B. T. H., Taylor, J. M., Bartee, E., Gouveia, K., Barry, M., & Früh, K. (2004) · Journal of Virology · doi:10.1128/jvi.79.1.597-601.2005 · Cited by 59
Rosales, R., Harris, N., Ahn, B. Y., & Moss, B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36783-2 · Cited by 56
Senkevich, T. G., Wolffe, E. J., & Buller, R. M. L. (1995) · Journal of Virology · doi:10.1128/jvi.69.7.4103-4111.1995 · Cited by 56
The vaccinia virus B1R kinase induces p53 downregulation by an Mdm2-dependent mechanism
Santos, C. R., Vega, F. M. D. L., Blanco, S., Barcia, R., & Lazo, P. A. (2004) · Virology · doi:10.1016/j.virol.2004.08.013 · Cited by 53
Gil, J., Rullás, J., Alcamı́, J., & Estéban, M. (2001) · Journal of General Virology · doi:10.1099/0022-1317-82-12-3027 · Cited by 49
Hel, Z., Nacsa, J., Tsai, W.-P., Thornton, A., Giuliani, L., Tartaglia, J., & Franchini, G. (2002) · Virology · doi:10.1006/viro.2002.1722 · Cited by 48
Mastrangelo, M. J., & Lattime, E. C. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700538 · Cited by 46
Poxvirus Infection Rapidly Activates Tyrosine Kinase Signal Transduction
Masters, J., Hinek, A. A., Shahab Uddin, M. S., Platanias, L. C., Zeng, W., McFadden, G., & Fish, E. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108019200 · Cited by 45
Self-citationMapping of a vaccinia host range sequence by insertion into the viral thymidine kinase gene
Gillard, S., Spehner, D., & Drillien, R. (1985) · Journal of Virology · doi:10.1128/jvi.53.1.316-318.1985 · Cited by 45
Katz, E., Ward, B. M., Weisberg, A. S., & Moss, B. (2003) · Journal of Virology · doi:10.1128/jvi.77.22.12266-12275.2003 · Cited by 45
Antigen gene transfer to cultured human dendritic cells using recombinant avipoxvirus vectors
Brown, M. D., Davies, D. H., Skinner, M. A., Bowen, G. P., Hollingsworth, S. J., Mufti, G. J., Arrand, J. R., & Stacey, S. (1999) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700014 · Cited by 43
Brown, M. D., Zhang, Y., Dermine, S., de Wynter, E. A., Hart, C. A., Kitchener, H. C., Stern, P. L., Skinner, M. A., & Stacey, S. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301288 · Cited by 42
Poxvirus vaccines for cancer and HIV therapy
Essajee, S. M., & Kaufman, H. L. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.4.575 · Cited by 38
Oncolytic Viruses: Programmable Tumour Hunters
Bell, J. C., Garson, K., Lichty, B. D., & Stojdl, F. (2002) · Current Gene Therapy · doi:10.2174/1566523024605582 · Cited by 37
Cell‐mediated cytotoxicity in recovery from poxvirus infections
Müllbacher, A. (2003) · Reviews in Medical Virology · doi:10.1002/rmv.381 · Cited by 35
Johnston, J. B., Nazarian, S. H., Natale, R., & McFadden, G. (2004) · Virology · doi:10.1016/j.virol.2004.11.030 · Cited by 35
Self-citationEnhanced resistance in STAT6-deficient mice to infection with ectromelia virus
Mahalingam, S., Karupiah, G., Takeda, K., Akira, S., Matthaei, K. I., & Foster, P. S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111151098 · Cited by 30
Hsiao, J., Chung, C.-S., Drillien, R., & Chang, W. (2004) · Virology · doi:10.1016/j.virol.2004.07.032 · Cited by 30
Brownstein, D. G., & Gras, L. (1997) · Europe PMC (PubMed Central) · Cited by 28
Infection with Vaccinia Virus Alters Regulation of Cell Cycle Progression
Wali, A., & Strayer, D. S. (1999) · DNA and Cell Biology · doi:10.1089/104454999314836 · Cited by 28
Apoptosis Regulator Genes Encoded by Poxviruses
Barry, M., Wasilenko, S. T., Stewart, T. L., & Taylor, J. M. (2004) · Progress in molecular and subcellular biology · doi:10.1007/978-3-540-74264-7_2 · Cited by 26
Interferon‐inducible chemokines and immunity to poxvirus infections
Mahalingam, S., Foster, P. S., Lobigs, M., Farber, J. M., & Karupiah, G. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.17720.x · Cited by 21
Resistance to ectromelia virus infection in mice Analysis ofH-2-linked gene effects
O'Neill, H. C. (1991) · Archives of Virology · doi:10.1007/bf01314035 · Cited by 4
Cited by
Randall, R. E., & Goodbourn, S. (2008) · Journal of General Virology · doi:10.1099/vir.0.83391-0 · Cited by 1,571
Cross-Species Virus Transmission and the Emergence of New Epidemic Diseases
Parrish, C. R., Holmes, E. C., Morens, D. M., Park, E.-C., Burke, D. S., Calisher, C. H., Laughlin, C. A., Saif, L. J., & Daszak, P. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00004-08 · Cited by 834
Monkeypox Virus in Nigeria: Infection Biology, Epidemiology, and Evolution
Alakunle, E., Moens, U., Nchinda, G., & Okeke, M. I. (2020) · Viruses · doi:10.3390/v12111257 · Cited by 812
History of Oncolytic Viruses: Genesis to Genetic Engineering
Kelly, E., & Russell, S. J. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300108 · Cited by 763
Monkeypox: disease epidemiology, host immunity and clinical interventions
Lum, F.-M., Torres-Ruesta, A., Tay, M. Z., Lin, R. T. P., Lye, D. C., Rénia, L., & Ng, L. F. P. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00775-4 · Cited by 541
Metadata
- Authors
- McFadden, G.
- Venue
- Nature Reviews Microbiology
- Published
- 2005-03
- Volume
- 3
- Issue
- 3
- Pages
- 201-213
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- OpenAlex
- W4211177539
- Cited by
- 523
- References
- 122
- FWCI
- 1.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.